D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
HCA Healthcare
HCA
$89.9B
| $922K | ﹤0.01% |
6,237
-40,546
| -87% | -$5.44M |
|
|
CAMP
3002
DELISTED
CalAmp Corp.
CAMP
| $922K | ﹤0.01% |
4,183
-9,109
| -69% | -$2.22M |
|
|
GHL
3003
DELISTED
Greenhill & Co., Inc.
GHL
| $922K | ﹤0.01% |
54,000
+26,190
| +94% | +$425K |
|
3004
Forestar Group
FOR
$1.51B
| $921K | ﹤0.01% |
44,154
-1,459
| -3% | -$28.5K |
|
|
ROIC
3005
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $918K | ﹤0.01% |
51,975
-105,702
| -67% | -$1.91M |
|
|
ROCC
3006
CALL
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $914K | ﹤0.01% |
30,100
| – | – |
|
3007
PUT
Madrigal Pharmaceuticals
MDGL
$12.5B
| $911K | ﹤0.01% |
10,000
-10,000
| -50% | -$970K |
|
3008
PUT
Methanex
MEOH
$4.23B
| $908K | ﹤0.01% |
23,500
-20,000
| -46% | -$750K |
|
3009
StoneX
SNEX
$8.65B
| $908K | ﹤0.01% |
94,092
+29,186
| +45% | +$242K |
|
|
CHNG
3010
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $907K | ﹤0.01% |
55,319
+36,319
| +191% | +$487K |
|
3011
PUT
Capital One
COF
$127B
| $906K | ﹤0.01% |
8,800
-4,300
| -33% | -$414K |
|
3012
Columbia Banking Systems
COLB
$8.79B
| $906K | ﹤0.01% |
22,277
-8,481
| -28% | -$330K |
|
3013
PUT
RLI Corp
RLI
$6.07B
| $900K | ﹤0.01% |
20,000
| – | – |
|
|
STEL
3014
DELISTED
Stellar Bancorp
STEL
| $897K | ﹤0.01% |
28,831
+15,316
| +113% | +$449K |
|
3015
Grupo Cibest SA
CIB
$21B
| $894K | ﹤0.01% |
+16,310
| New | +$843K |
|
|
ARA
3016
DELISTED
American Renal Associates Holdings, Inc
ARA
| $892K | ﹤0.01% |
86,029
-1,125
| -1% | -$9.62K |
|
|
RDUS
3017
CALL
DELISTED
Radius Health, Inc.
RDUS
| $891K | ﹤0.01% |
44,200
| – | – |
|
|
ARD
3018
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $890K | ﹤0.01% |
45,432
+13,110
| +41% | +$241K |
|
3019
Hilton Worldwide
HLT
$72.9B
| $889K | ﹤0.01% |
8,017
-2,745
| -26% | -$275K |
|
3020
Corporacion America
CAAP
$4.28B
| $886K | ﹤0.01% |
147,652
+84,767
| +135% | +$380K |
|
|
GMS
3021
DELISTED
GMS Inc
GMS
| $883K | ﹤0.01% |
32,602
-175,098
| -84% | -$5.14M |
|
3022
PUT
Incyte
INCY
$25.1B
| $882K | ﹤0.01% |
10,100
| – | – |
|
3023
Motorcar Parts of America
MPAA
$271M
| $878K | ﹤0.01% |
39,836
-33,955
| -46% | -$656K |
|
3024
PUT
Xerox
XRX
$354M
| $878K | ﹤0.01% |
23,800
| – | – |
|
3025
American States Water
AWR
$3.49B
| $873K | ﹤0.01% |
10,081
-9,267
| -48% | -$821K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.